5Vote!
Chicago Tribune (Free subscription) | 11/26/2009
Facility would be used to make flu, pandemic vaccines Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.
5Vote!
Chicago Tribune (Free subscription) | 11/26/2009
Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.
4Vote!
Tuscaloosanews.com (Free subscription) | 11/26/2009
Though still early, the work of Dr. Douglas Losordo that uses technology developed by Baxter International Inc. is being watched closely by the stem cell research community. The trial data, presented Tuesday afternoon at the American Heart Association scientific conference in Orlando, is also important in the study of heart disease, the leading cause of death in the U.S.
4Vote!
WSJ.com (Free subscription) | 11/25/2009
It isn't clear how many benefits cell-culture technology will offer. A spokeswoman for Illinois-based Baxter International Inc. said the company's cell-culture plant in the Czech Republic—one of the first large-scale cell-culture facilities—initially experienced the same difficulty growing the H1N1 virus that egg-based plants did. Like other drug makers, Baxter managed to improve the...